Recombinant Human ANGPTL8 (N-Fc)

Description

EnkiLife provides the Recombinant Human ANGPTL8 (N-Fc) protein,aslo know as Betatrophin;Angiopoietin-like protein 8;Lipasin;Angptl8, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Angiopoietin-like Protein 8 is produced by our Mammalian expression system and the target gene encoding Ala22-Ala198 is expressed with a human IgG1 Fc tag at the N-terminus.Accession:Q6UXH0. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:46 KDa. Background:The protein specifically promotes pancreatic beta cell proliferation and beta cell mass expansion, thereby improving glucose tolerance. It promotes pancreatic beta cell proliferation without insulin resistance. Also it acts as a blood lipid regulator by regulating serum triglyceride levels and possibly by promoting ANGPTL3 cleavage. It interacts with ANGPTL3. It predominantly expressed in liver and also expressed in adipose tissues. The ability of the protein to induce pancreatic beta cell proliferation is promising in diabetes therapy. Betatrophin treatment could supply or replace insulin injections by increasing the number of insulin-producing cells in diabetes.